FDA’s Pharmacoepidemiology Studies Could Be Funded Through Reagan-Udall
Executive Summary
The Reagan-Udall Foundation could fund and select investigators for post-market pharmacoepidemiological studies on behalf of the FDA, a participant at an agency workshop suggested
You may also be interested in...
FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt
FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends
FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt
FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends
FDA Safety Monitoring Could Rely On Data Links, Menactra Model – McClellan
Former FDA Commissioner Mark McClellan was one of the main drivers behind the language in the FDA Amendments Act mandating an active surveillance system, and he continues to be involved in shaping the program how will be implemented